MARIAH CLUSS: Open Payments
NPI 1093327983 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 10 payments from 5 companies in 2025. Trend: 2023 $314 · 2024 $337 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $149 |
| ABBVIE INC. | 2 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: QULIPTA, Ozempic, JARDIANCE, MOUNJARO, Wegovy, TRELEGY ELLIPTA, Rybelsus.
Industry payments across VA — which companies pay providers there.
